Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.51 |
| ▸ | OXTR | P30559 | 1/20 | 0.51 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.51 |
| ▸ | PTGES | O14684 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | PYGL | P06737 | 5/20 | 0.47 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1805967 | 0.81 | SMN1; SMN2 (0.64) | TSHRCYP1A2CYP2C19CYP2D6ALDH1A1 | |
| SCHEMBL1806599 | 0.80 | CYP1A2 (0.79) | TSHRCYP1A2CYP2C19CYP2D6ALDH1A1 | |
| SCHEMBL164411 | 0.79 | HPGD (0.53) | ALDH1A1HPGDSMN1; SMN2MAPK1PYGL | |
| SCHEMBL14012583 | 0.79 | HPGD (0.53) | ALDH1A1HPGDSMN1; SMN2MAPK1PYGL | |
| SCHEMBL27814976 | 0.79 | GRM4 (0.49) | AVPR2OXTRAVPR1APTGESHPGD | |
| SCHEMBL21367386 | 0.78 | NR3C2 (0.44) | TSHRCYP1A2CYP2C19CYP2D6ALDH1A1 | |
| SCHEMBL27704273 | 0.78 | AVPR2 (0.51) | CYP1A2CYP2C19AVPR2OXTRAVPR1A | |
| SCHEMBL31187273 | 0.76 | TSHR (0.68) | TSHRCYP1A2CYP2C19CYP2D6ALDH1A1 | |
| SCHEMBL1803117 | 0.76 | TSHR (0.68) | TSHRCYP1A2CYP2C19CYP2D6ALDH1A1 | |
| SCHEMBL1802753 | 0.76 | NR3C2 (0.40) | TSHRCYP1A2CYP2C19CYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2322502-B1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| EP-2322502-B1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-9394240-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9394240-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2322502-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2011-05-18 | — | — | EP | disclosed |
| EP-2322502-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2011-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | TSHR 56/4885CYP1A2 143/4885CYP2C19 1149/4885 |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | TSHR 56/4885CYP1A2 143/4885CYP2C19 1149/4885 |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | TSHR 56/4885CYP1A2 143/4885CYP2C19 1149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.